Nikko Asset Management Americas, Inc. 13D and 13G filings for Twist Bioscience Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 2:38 pm Sale |
2024-09-30 | 13G | Twist Bioscience Corporation TWST |
Nikko Asset Management Americas, Inc. | 2,860,847 4.880% |
-722,596 (-20.16%) |
Filing |
| 2024-02-12 5:55 pm Purchase |
2023-12-31 | 13G | Twist Bioscience Corporation TWST |
Nikko Asset Management Americas, Inc. | 3,583,443 6.210% |
649,410 (+22.13%) |
Filing |
| 2023-02-10 10:30 am Purchase |
2022-12-31 | 13G | Twist Bioscience Corporation TWST |
Nikko Asset Management Americas, Inc. | 2,934,033 5.180% |
2,934,033 (New Position) |
Filing |